Research & Development



  一片陰雲路過冰川,灑下了淅淅瀝瀝的小雨。雨水進入冰川之後轉瞬間就變成了雪花緩緩落下。 第一三零章 倒霉的董仲舒新超碰97在线观看   一旦他們來了,自己這群當初在山東遭受白眼,壓迫的人,不可能是他們的對手。任你干   李廣利拱手道︰“舍妹生產之時,某家就守衛在舍妹身邊,一干飲食用度,都是某家親自檢驗,飯食飲水更是親自嘗過之後舍妹才會進食,如果舍妹在這樣的環境下依舊被奸人所害,李某認了。”在线精品视频/这里总有您喜欢的任你干   “如此說來,君侯要把馬房從武威郡遷出?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo